The Federal Circuit recently held that makers of biosimilars must always notify brand-name rivals six months before commercial product launch. Brian Klock and Kathryn Easterling report.
08/03/2016 | Managing Intellectual Property Blog
1 min
July 28, 2020
July 14, 2020
July 09, 2020
July 31, 2020
July 27, 2020
July 23, 2020